Early Warning News Release Regarding the Issuance of Securities of ZYUS Life Sciences Corporation#Early #Warning #News…
Tag: Sciences
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension…
Usana Health Sciences chief legal officer sells $186,513 in stock
Usana Health Sciences chief legal officer sells $186,513 in stock#Usana #Health #Sciences #chief #legal #officer #sells…
Gilead Sciences CFO sells $2.1 million in stock
Gilead Sciences CFO sells $2.1 million in stock#Gilead #Sciences #CFO #sells #million #stock
Gilead Sciences, Inc. (GILD) Leerink Partners Global Healthcare Conference – (Transcript)
Gilead Sciences, Inc. (GILD) Leerink Partners Global Healthcare Conference – (Transcript) #Gilead #Sciences #GILD #Leerink #Partners…
Wave Life Sciences CEO Paul Bolno sells shares worth $1.62 million
Wave Life Sciences CEO Paul Bolno sells shares worth $1.62 million#Wave #Life #Sciences #CEO #Paul #Bolno…
Thermo Fisher Scientific Stock: Strong Q4 Strategic M&A Growth In Life Sciences (NYSE:TMO)
This article was written by Follow I’m an insurance Case Manager with a deep interest in…
Why Gilead Sciences Stock Remains A Buy After A 40% Rally (NASDAQ:GILD)
This article was written by Follow With over two decades of dedicated experience in investment, Allka…
Roivant Sciences president Eric Venker sells $1.07 million in shares
Roivant Sciences president Eric Venker sells $1.07 million in shares#Roivant #Sciences #president #Eric #Venker #sells #million…
Saba capital management sells $1,388 in Abrdn life sciences stock
Saba capital management sells $1,388 in Abrdn life sciences stock#Saba #capital #management #sells #Abrdn #life #sciences…
Gilead Sciences: Diversification Strategy Not Derisked Enough Yet
Gilead Sciences: Diversification Strategy Not Derisked Enough Yet #Gilead #Sciences #Diversification #Strategy #Derisked
SAVA IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 10 Deadline in Secu
SAVA IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Cassava Sciences, Inc. Investors with Losses…
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action – SAVA
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important February 10…
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York–(Newsfile Corp. – January 25, 2025) – WHY: Rosen Law Firm, a global…
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York–(Newsfile Corp. – January 24, 2025) – WHY: Rosen Law Firm, a global investor…
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York–(Newsfile Corp. – January 14, 2025) – WHY: Rosen Law Firm, a global investor…
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York–(Newsfile Corp. – January 1, 2025) – WHY: Rosen Law Firm, a global investor…
Roivant Sciences’ president sells common shares worth $4.1 million By Investing.com
Eric Venker, the President and Chief Operating Officer of Roivant Sciences Ltd. (NASDAQ:), recently executed a…
A Securities Fraud Class Action Lawsuit Was Filed Against Cassava Sciences, Inc. (SAVA) By Investing.com
RADNOR, PA – (NewMediaWire) – December 30, 2024 – The law firm of Kessler Topaz Meltzer…
Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise
Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise #Gilead #Sciences #Preview #Buy #Thriving…
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor…
BlackRock Health Sciences Opportunities Fund Q4 2024 Commentary (Mutual Fund:SHSSX)
This article was written by Follow BlackRock’s purpose is to help more and more people experience…